The Licensing Executive Society (LES) Chemicals, Energy, Environmental and Materials Sector (CEEM), in coordination with the LES International CEEM Sector recently released its first “LES CEEM Royalty Rates and Deal Terms Survey.”
This survey provides a unique industry sector perspective on licensing royalty rates and deal terms not found in other licensing or royalty rate publications. For example, the report illustrates the impact that other financial components and the stage of technology development can have on a negotiated royalty rate. In addition, the report illustrates differences in royalty rates when an academic institution is involved in the deal or when the deal is for an exclusive versus a non-exclusive license.
LES also recently released the “LES Global BioPharma Royalty Rates and Deal Terms Survey.” Survey participants were members of the biotechnology and pharmaceutical industries and their responses provide a detailed analysis of fixed royalties, tiered royalties, deal terms and valuation methods. This survey includes data based on stage of development, therapeutic area types and peak annual sales.
The LES press release announcing these surveys can be found here
As chairman of the CEEM Survey committee I encourage all in the licensing community to join LES and obtain a copy of the survey findings.
categorized under: Biotechnology, Chemical, Compliance, Deal Terms, Energy, Environmental, LES, Licensing, Materials, Royalty Rates
View All